Weighted average remaining contractual life of outstanding other equity instruments

No definition available.

Name:	asnd_WeightedAverageRemainingContractualLifeOfOutstandingOtherEquityInstruments
Namespace Prefix:	asnd_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Year of grant of warrants.

+ References

No definition available.

+ Details

Name:	asnd_YearOfGrantOfWarrants
Namespace Prefix:	asnd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.

+ References

+ Details

Name:	ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]

+ References

+ Details

Name:	ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]

+ References

+ Details

Name:	ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_GrantedBeforeJanuary12023Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_GrantedIn2023Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_GrantedInTwoThousandTwentyFourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=asnd_GrantedIn2025Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Share-based Payment - Schedule of Weighted Average Exercise Price and Weighted Remaining Contractual Life for Outstanding Warrants (Detail)	12 Months Ended
	Dec. 31, 2025 shares € / shares	Dec. 31, 2024 € / shares	Dec. 31, 2023 € / shares	Dec. 31, 2022 € / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of Warrants, Outstanding	5,222,591
Weighted Average Exercise, Outstanding	€ 103.24	€ 93.25	€ 86.38	€ 81.3
Weighted Average Life, Granted	61 months
Granted before January 1, 2023 [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Year of grant	January 1, 2023
Number of Warrants, Granted \| shares	4,208,147
Weighted Average Exercise, Granted	€ 97.25
Weighted Average Life, Granted	50 months
Granted in 2023 [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Year of grant	2023
Number of Warrants, Granted	175,231
Weighted Average Exercise, Granted	€ 92.48
Weighted Average Life, Granted	89 months
Granted in 2024 [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Year of grant	2024
Number of Warrants, Granted	430,190
Weighted Average Exercise, Granted	€ 122.52
Weighted Average Life, Granted	102 months
Granted in 2025 [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Year of grant	2025
Number of Warrants, Granted	409,023
Weighted Average Exercise, Granted	€ 149.15
Weighted Average Life, Granted	113 months